Publications by authors named "Samuel Banister"

Claim this Profile
C
Cannabinoid-like compounds found in non-cannabis plants exhibit antiseizure activity in genetic mouse models of drug-resistant epilepsy.
Ka Lai Yip, Michael Udoh, Laura A Sharman, Thomas Harman, Miguel Bedoya-Pérez, Samuel D Banister

Epilepsia· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Activity Relationships, Deuteration, and Fluorination of Synthetic Cannabinoid Receptor Agonists Related to AKB48, 5F-AKB-48, and AFUBIATA.
Eric Sparkes, Callan J Maloney, Jack W Markham, Chianna Dane, Rochelle Boyd, Samuel D Banister

ACS Chem Neurosci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA.
Eric Sparkes, Jack W Markham, Rochelle Boyd, Michael Udoh, Rebecca Gordon, Samuel D Banister

RSC Med Chem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA.
Eric Sparkes, Axelle Timmerman, Jack W Markham, Rochelle Boyd, Rebecca Gordon, Samuel D Banister

ACS Chem Neurosci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB receptor.
Beth Ryalls, Monica Patel, Eric Sparkes, Samuel D Banister, David B Finlay

Biochem Pharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB receptor.
Monica Patel, Natasha L Grimsey, Samuel D Banister, David B Finlay, Michelle Glass

Pharmacol Res Perspect· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy.
Thomas Harman, Michael Udoh, Dan L McElroy, Lyndsey L Anderson, Richard C Kevin, Samuel D Banister

Front Physiol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA.
Liesl K Janssens, Adam Ametovski, Eric Sparkes, Rochelle Boyd, Felcia Lai, Samuel D Banister

ACS Chem Neurosci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of AMB-FUBINACA metabolism and CB-mediated activity of its acid metabolite.
Hunter D J Webb, David B Finlay, Shuli Chen, Andrea J Vernall, Eric Sparkes, Samuel D Banister

Forensic Toxicol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome.
Lyndsey L Anderson, Dilara A Bahceci, Nicole A Hawkins, Declan Everett-Morgan, Samuel D Banister

PLoS One· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11.
Richard C Kevin, Elizabeth A Cairns, Rochelle Boyd, Jonathon C Arnold, Michael T Bowen, Samuel D Banister

Front Psychiatry· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs.
Eric Sparkes, Rochelle Boyd, Shuli Chen, Jack W Markham, Jia Lin Luo, Samuel D Banister

Front Psychiatry· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Evaluation of F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration in rodents and in human tissue: Erratum.
François-Xavier Lepelletier, Matthias Vandesquille, Marie-Claude Asselin, Christian Prenant, Andrew C Robinson, Samuel D Banister

Theranostics· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function.
Carol J Milligan, Lyndsey L Anderson, Michael T Bowen, Samuel D Banister, Iain S McGregor

J Cannabis Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transporters.
Maia G Etchart, Lyndsey L Anderson, Adam Ametovski, Peter M Jones, Anthony M George, Samuel D Banister

Eur J Pharmacol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (Ca3) Inhibitors.
Richard C Kevin, Somayeh Mirlohi, Jamie J Manning, Rochelle Boyd, Elizabeth A Cairns, Samuel D Banister

ACS Chem Neurosci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Steric Requirements at CB and CB Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues.
Jack Markham, Eric Sparkes, Rochelle Boyd, Shuli Chen, Jamie J Manning, Samuel D Banister

ACS Chem Neurosci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of valine, -leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA.
Eric Sparkes, Elizabeth A Cairns, Richard C Kevin, Felcia Lai, Katharina Elisabeth Grafinger, Samuel D Banister

RSC Med Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome.
Lyndsey L Anderson, Michael Udoh, Declan Everett-Morgan, Marika Heblinski, Iain S McGregor, Samuel D Banister

J Cannabis Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Synthetic cannabis': A dangerous misnomer.
Shane Darke, Samuel Banister, Michael Farrell, Johan Duflou, Julia Lappin

Int J Drug Policy· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?
Adam Ametovski, Elizabeth A Cairns, Katharina Elisabeth Grafinger, Annelies Cannaert, Marie H Deventer, Samuel D Banister

ACS Chem Neurosci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB receptor activation assays-Part II: Structure activity relationship assessment via a β-arrestin recruitment assay.
Katharina Elisabeth Grafinger, Annelies Cannaert, Adam Ametovski, Eric Sparkes, Elizabeth Cairns, Samuel D Banister

Drug Test Anal· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB receptor activation assays: Part I-Synthesis, analytical characterization, and binding affinity for human CB receptors.
Edward Pike, Katharina Elisabeth Grafinger, Annelies Cannaert, Adam Ametovski, Jia Lin Luo, Samuel D Banister

Drug Test Anal· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays.
Katharina Elisabeth Grafinger, Marthe M Vandeputte, Annelies Cannaert, Adam Ametovski, Eric Sparkes, Samuel D Banister

Drug Test Anal· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the complex pharmacology of cannabidiol: Mounting evidence suggests a common binding site with cholesterol.
Lewis J Martin, Samuel D Banister, Michael T Bowen

Pharmacol Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis